Enskede, Sweden

Lars Sandberg


 

Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Lars Sandberg: Innovator in Pharmaceutical Research

Introduction

Lars Sandberg is a notable inventor based in Enskede, Sweden. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds for therapeutic use. With a total of 4 patents, his work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Among his latest patents, Sandberg has developed compounds such as 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives. These compounds are useful in therapy for treating cancers, inflammation, autoimmune diseases, and graft-versus-host diseases, particularly in transplantation patients. Another significant patent involves tetrahydroindazoles, which are designed for the treatment of cancer and the prevention of viral infections.

Career Highlights

Throughout his career, Lars Sandberg has worked with esteemed organizations, including the Thomas Helledays Stiftelse För Medicinsk Forskning and Genase Therapeutics B.V. His research has been pivotal in advancing therapeutic options in the medical field.

Collaborations

Sandberg has collaborated with notable colleagues such as Martin Haraldsson and Sonia Lain, contributing to a dynamic research environment that fosters innovation.

Conclusion

Lars Sandberg's contributions to pharmaceutical research and his innovative patents highlight his role as a key figure in the development of new therapeutic compounds. His work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…